FDA Adverse Event Injury Summary report: N

DEXCOM G7 CONTINUOUS GLUCOSE MONITORING SYSTEM

MDR report key: 23022592 · Received September 10, 2025

Report

Report Number
3004753838-2025-254171
Event Type
Injury
Date Received
September 10, 2025
Date of Event
August 27, 2025
Report Date
September 10, 2025
Manufacturer
DEXCOM, INC.
Product Code
QBJ
PMA / PMN Number
K213919
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AZ, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

(B)(4). LABELING INDICATES: INSERTING THE SENSOR AND WEARING THE ADHESIVE PATCH MIGHT CAUSE INFECTION, BLEEDING, PAIN OR SKIN IRRITATIONS (E.G. REDNESS, SWELLING, BRUISING, ITCHING, SCARRING OR SKIN DISCOLORATION).

Description of Event or Problem · 0

IT WAS REPORTED THAT A SKIN REACTION ISSUE OCCURRED. THE WEARABLE WAS INSERTED INTO THE ARM ON (B)(6) 2025. THE PATIENT EXPERIENCED A SKIN REACTION AND INFECTION THAT DEVELOPED SEVEN DAYS AFTER SENSOR INSERTION IN THE ARM. THE AREA HAD BEEN PREPPED WITH ALCOHOL PRIOR TO INSERTION. THE PATIENT REPORTED SYMPTOMS INCLUDING RASH, REDNESS, INFLAMMATION, AND AN INFECTION EXTENDING BEYOND THE PATCH PERIMETER. ON (B)(6) 2025, THE PATIENT CONSULTED A PHYSICIAN, WHO PRESCRIBED DOXYCYCLINE HYC 100 MG, TO BE TAKEN TWICE DAILY. IT WAS UNSPECIFIED WHETHER THE SYMPTOMS ORIGINATED AT THE NEEDLE PUNCTURE SITE OR BENEATH THE SENSOR PATCH, AND THE PATIENT¿S CONDITION FOLLOWING TREATMENT WAS NOT REPORTED. NO DATA OR PRODUCT WAS PROVIDED FOR INVESTIGATION. THE ALLEGATION WAS UNDETERMINED. THE PROBABLE CAUSE COULD NOT BE DETERMINED. NO ADDITIONAL EVENT OR PATIENT INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1777654 DEXCOM G7 CONTINUOUS GLUCOSE MONITORING SYSTEM CONTINUOUS GLUCOSE MONITOR QBJ DEXCOM, INC. NI NI

Patients

Seq Age Sex Outcome Treatment
1 44 YR Female Other